First Randomized Controlled Trial Shows Promise of a Ketogenic Diet in Psychotic Disorders

Contributed by: Business Wire

Logo

Images

First Randomized Controlled Trial Shows Promise of a Ketogenic Diet in Psychotic Disorders

Business Wire embedded0

Tags

Mental Health

Research

Hospitals

Fitness & Nutrition

Clinical Trials

Health

General Health

Other Science

Science

Baszucki Group

More Like This

New Bipolar Disorder Study Shows that a Ketogenic Diet Leads to Mental and Physical Health Benefits

Baszucki Group Funds £1.17 Million for University of Oxford Trial of Ketogenic Therapy for Early Psychosis

Baszucki Group Funds Oxford University Clinical Trial of Ketogenic Therapy for Early Psychosis

New Evidence Offers Hope for Ketogenic Therapy in Weight-Normalized Anorexia Nervosa

New Evidence Offers Hope for Ketogenic Therapy in Treatment of Anorexia Nervosa

Deanna Kelly, PharmD, BCPP, Live It, Launch It program lead

University of Maryland Launches Innovative Clinician Training Program in Ketogenic Metabolic Therapy for Mental Health

Baszucki Group 2025 Metabolic Psychiatry Scholar Award Recipients

Baszucki Group Announces Six Recipients of the Metabolic Psychiatry Scholar Award for Emerging Scientific Leaders Advancing Mental Health Innovation

Baszucki Group and Cleveland Clinic Neurological Institute expand impact of landmark brain study to investigate metabolic health markers

Cleveland Clinic Neurological Institute and Baszucki Group Team Up to Advance Landmark Brain Study with Metabolic Health Markers

Gedeon Richter presents analysis on cannabis usage among patients with schizophrenia: a new medical solution to a severe issue might be available

PR Newswire associated0

New National Survey of Healthcare Providers Offers Insights Into the Dynamic and Challenging Treatment Journey for People Living With Schizophrenia or Bipolar I Disorder